MedPath

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Not Applicable
Recruiting
Conditions
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Registration Number
NCT05462145
Lead Sponsor
Kardium Inc.
Brief Summary

This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
549
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Effectiveness endpoint12 months

Number of subjects with freedom from documented atrial fibrillation, atrial flutter, and atrial tachycardia (AF/AFL/AT) 12 months post-procedure.

Safety endpoint7 days

Rate of subjects presenting with one or more of the specified primary safety events within 7 days of the index ablation procedure.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (20)

Texas Cardiac Arrhythmia Research Foundation

🇺🇸

Austin, Texas, United States

University of Alabama Heersink School of Medicine

🇺🇸

Birmingham, Alabama, United States

Grandview Medical Center

🇺🇸

Birmingham, Alabama, United States

St. Bernards Medical Center

🇺🇸

Jonesboro, Arkansas, United States

Sutter Health - California Pacific Medical Center

🇺🇸

San Francisco, California, United States

St. Vincent's Medical Center

🇺🇸

Jacksonville, Florida, United States

Mercy Hospital

🇺🇸

Miami, Florida, United States

Johns Hopkins

🇺🇸

Baltimore, Maryland, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Scroll for more (10 remaining)
Texas Cardiac Arrhythmia Research Foundation
🇺🇸Austin, Texas, United States
Texas Cardiac Arrhythmia Research Foundation 3000 N. IH-35, Ste 705, TX 78705, USA
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.